Cargando…

Functional in silico analysis of human tyrosinase and OCA1 associated mutations

Oculocutaneous albinism type 1 (OCA1) is an autosomal recessive disorder caused by mutations in the tyrosinase gene. OCA1 exists in two forms: OCA1A and OCA1B. OCA1A is caused by a full loss of the human tyrosinase protein (Tyr), leading to an absence of pigment in skin, hair, and eyes, while OCA1B...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Milan, Sergeev, Yuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808255/
https://www.ncbi.nlm.nih.gov/pubmed/33458560
_version_ 1783636867623682048
author Patel, Milan
Sergeev, Yuri
author_facet Patel, Milan
Sergeev, Yuri
author_sort Patel, Milan
collection PubMed
description Oculocutaneous albinism type 1 (OCA1) is an autosomal recessive disorder caused by mutations in the tyrosinase gene. OCA1 exists in two forms: OCA1A and OCA1B. OCA1A is caused by a full loss of the human tyrosinase protein (Tyr), leading to an absence of pigment in skin, hair, and eyes, while OCA1B has reduced Tyr catalytic activity and pigment. The current understanding of the disease is hampered by the absence of information regarding the alterations of protein structure and the effects leading to either form of OCA1. Here, we used computational methods to find a general mechanism for establishing this link. Tyr and mutant variants were built through homology modeling, glycosylated in silico, minimized, and simulated using 100 ns molecular dynamics in water. For OCA1B mutants, cavity size is linked to ΔΔG values for mutants, suggesting that partial loss of Tyr is associated with the destabilizing effect of the EGF-like domain movement. In OCA1A, active site mutation simulations indicate that the absence of O(2) leads to protein instability. OCA1B mutants are described in severity by the size of the cavity within the EGF–Tyr interface, while active site OCA1A mutants are unable to fully coordinate copper, leading to an absence of O(2) and Tyr instability. In patients with known genotypes, free energy changes may help identify the severity of the disease by assessing either the allosteric effect of the EGF-Tyr cavity in OCA1B or the active site instability in OCA1A.
format Online
Article
Text
id pubmed-7808255
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-78082552021-01-14 Functional in silico analysis of human tyrosinase and OCA1 associated mutations Patel, Milan Sergeev, Yuri J Anal Pharm Res Article Oculocutaneous albinism type 1 (OCA1) is an autosomal recessive disorder caused by mutations in the tyrosinase gene. OCA1 exists in two forms: OCA1A and OCA1B. OCA1A is caused by a full loss of the human tyrosinase protein (Tyr), leading to an absence of pigment in skin, hair, and eyes, while OCA1B has reduced Tyr catalytic activity and pigment. The current understanding of the disease is hampered by the absence of information regarding the alterations of protein structure and the effects leading to either form of OCA1. Here, we used computational methods to find a general mechanism for establishing this link. Tyr and mutant variants were built through homology modeling, glycosylated in silico, minimized, and simulated using 100 ns molecular dynamics in water. For OCA1B mutants, cavity size is linked to ΔΔG values for mutants, suggesting that partial loss of Tyr is associated with the destabilizing effect of the EGF-like domain movement. In OCA1A, active site mutation simulations indicate that the absence of O(2) leads to protein instability. OCA1B mutants are described in severity by the size of the cavity within the EGF–Tyr interface, while active site OCA1A mutants are unable to fully coordinate copper, leading to an absence of O(2) and Tyr instability. In patients with known genotypes, free energy changes may help identify the severity of the disease by assessing either the allosteric effect of the EGF-Tyr cavity in OCA1B or the active site instability in OCA1A. 2020 2020-08-24 /pmc/articles/PMC7808255/ /pubmed/33458560 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially.
spellingShingle Article
Patel, Milan
Sergeev, Yuri
Functional in silico analysis of human tyrosinase and OCA1 associated mutations
title Functional in silico analysis of human tyrosinase and OCA1 associated mutations
title_full Functional in silico analysis of human tyrosinase and OCA1 associated mutations
title_fullStr Functional in silico analysis of human tyrosinase and OCA1 associated mutations
title_full_unstemmed Functional in silico analysis of human tyrosinase and OCA1 associated mutations
title_short Functional in silico analysis of human tyrosinase and OCA1 associated mutations
title_sort functional in silico analysis of human tyrosinase and oca1 associated mutations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808255/
https://www.ncbi.nlm.nih.gov/pubmed/33458560
work_keys_str_mv AT patelmilan functionalinsilicoanalysisofhumantyrosinaseandoca1associatedmutations
AT sergeevyuri functionalinsilicoanalysisofhumantyrosinaseandoca1associatedmutations